Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Unveiling the Essentials of Synopsys Stock

Today we're going to take a closer look at Large-Cap Technology company Synopsys, whose shares are currently trading at $483.0. We've been asking ourselves whether the company is under or over valued at today's prices... let's perform a brief value analysis to find out!

a Lower P/B Ratio Than Its Sector Average but Its Shares Are Expensive:

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company belongs to the Technology sector, which has an average price to earnings (P/E) ratio of 30.44 and an average price to book (P/B) ratio of 4.19. In contrast, Synopsys has a trailing 12 month P/E ratio of 65.4 and a P/B ratio of 3.24.

Synopsys has moved -5.2% over the last year compared to 16.3% for the S&P 500 — a difference of -21.5%. Synopsys has a 52 week high of $651.73 and a 52 week low of $365.74.

Wider Gross Margins Than the Industry Average of 63.49%:

2019 2020 2021 2022 2023 2024
Revenue (M) $3,361 $3,685 $4,204 $4,616 $5,318 $6,127
Gross Margins 78% 78% 80% 81% 81% 80%
Net Margins 16% 18% 18% 21% 23% 37%
Net Income (M) $532 $664 $758 $985 $1,230 $2,263
Net Interest Expense (M) $12 $5 $3 $2 $1 $67
Depreciation & Amort. (M) $202 $210 $204 $228 $247 $163
Diluted Shares (M) 154 156 157 156 155 156
Earnings Per Share $3.45 $4.27 $4.81 $6.29 $7.92 $14.51
EPS Growth n/a 23.77% 12.65% 30.77% 25.91% 83.21%
Avg. Price $123.24 $185.8 $287.66 $307.02 $514.91 $480.11
P/E Ratio 34.72 42.23 58.0 47.67 63.73 32.48
Free Cash Flow (M) $602 $837 $1,399 $1,602 $1,514 $1,284
CAPEX (M) $198 $155 $94 $137 $190 $123
EV / EBITDA 24.88 32.92 45.61 32.97 50.54 46.31
Total Debt (M) $138 $128 $100 $21 $18 $16
Net Debt / EBITDA -0.82 -1.33 -1.42 -1.01 -0.93 -2.56
Current Ratio 0.99 1.19 1.16 1.09 1.15 2.44

Synopsys has exceptional EPS growth, generally positive cash flows, and an excellent current ratio of 2.44. The company also benefits from rapidly growing revenues and decreasing reinvestment in the business, wider gross margins than its peer group, and healthy leverage levels.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS